Located in the heart of Europe, CRS operates three advanced research units in Germany, equipped with over 160 beds. Situated in major metropolitan areas, these facilities serve a population of approximately 17.5 million people, ensuring efficient recruitment for large-scale, long-term clinical trials and early proof-of-concept studies.
With strategic locations, extensive expertise, and a commitment to excellence, we are your ideal partner for success.
Our Berlin Unit is dedicated to women’s health studies, expertly conducting both in-house and outpatient early-phase clinical trials. The Berlin team boasts extensive experience across a wide range of trial designs, ensuring high-quality research outcomes.
CRS Mannheim is renowned for its expertise in Phase I and II clinical trials, particularly in the cardiometabolic field. As the largest Phase I/II clinic, our Mannheim Unit addresses the full spectrum of clinical trial challenges while upholding the highest quality standards.
